AD is known for the accumulation of beta-amyloid plaques and tau tangles in the brain (19) and is often characterized by metabolic abnormalities, including compromised bioenergetics, impaired lipid metabolism, and an overall decreased metabolic capacity (60). The gene discussed is MAPT; the disease is Alzheimer disease.